entertainment -WSS

entertainment

author：fashion 2025-09-06 01:57:34 - browse：52517

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： STAT Virtual Event: The State of Biosimilars: What to Watch

leisure time

knowledge

WSS

Chan Zuckerberg Biohub Chicago to focus on inflammation

When women are denied an abortion, their children fare worse than peers

Key House panel plots a new health care package

Phenylephrine and the overlooked value of the placebo effect

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

STAT Virtual Event: The State of Biosimilars: What to Watch

entertainment

entertainment

hotspot

Walensky prepares to leave CDC — and Congress — behind

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Moonlake's readout produced a cash windfall. Risks remain

FDA panel signals lack of confidence in Amgen cancer drug data

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Group opposing PBM reform sets lobbying record

Wildfire smoke exposes gaps in outdoor worker protections

AI can’t replace a physician’s gut feeling

Hollywood unions extend contract negotiations for actors

Google and Epic fight stronger regulation of AI in health care

leisure time

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Group opposing PBM reform sets lobbying record

VC firm General Catalyst wants to buy a health system

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Chan Zuckerberg Biohub Chicago to focus on inflammation

Senate panel eyes new effort on drug shortages

hotspot

leisure time

knowledge

entertainment